Whereas cardiovascular disease-related mortality has declined in most developed countries, its known prevalence is increasing worldwide, although few data on the causes of heart disease in the ...
In adults aged 60 years and older, RSV vaccines had a pooled VE against hospitalization of 79% (95% CI, 72-85) across 3 case-control studies. Effectiveness was similar in immunocompromised adults ...